Catalyst Pharmaceuticals Inc (CPRX)
20.00
+0.12
(+0.60%)
USD |
NASDAQ |
Oct 04, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Shareholders Equity (Annual): 387.88M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 387.88M |
| December 31, 2022 | 300.42M |
| December 31, 2021 | 206.83M |
| December 31, 2020 | 169.60M |
| December 31, 2019 | 87.63M |
| December 31, 2018 | 50.78M |
| December 31, 2017 | 80.96M |
| December 31, 2016 | 39.31M |
| December 31, 2015 | 55.48M |
| December 31, 2014 | 35.24M |
| December 31, 2013 | 21.39M |
| Date | Value |
|---|---|
| December 31, 2012 | 14.62M |
| December 31, 2011 | 3.761M |
| December 31, 2010 | 5.518M |
| December 31, 2009 | 7.618M |
| December 31, 2008 | 10.56M |
| December 31, 2007 | 16.32M |
| December 31, 2006 | 19.85M |
| December 31, 2005 | 0.4465M |
| December 31, 2004 | 0.1176M |
| December 31, 2002 | 0.0449M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
87.63M
Minimum
2019
387.88M
Maximum
2023
230.47M
Average
206.83M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Sarepta Therapeutics Inc | 859.34M |
| Vertex Pharmaceuticals Inc | 17.58B |
| Regenxbio Inc | 311.74M |
| Edgewise Therapeutics Inc | 318.83M |
| Entrada Therapeutics Inc | 242.36M |